Kinetic studies on the AR (aldose reductase) protein have shown that it does not behave as a classical enzyme in relation to ring aldose sugars. As with non-enzymatic glycation reactions, there is probably a freeradical element involved derived from monosaccharide autoxidation. In the case of AR, there is free radical oxidation of NADPH by autoxidizing monosaccharides, which is enhanced in the presence of the NADPHbinding protein. Thus any assay for AR based on the oxidation of NADPH in the presence of autoxidizing monosaccharides is invalid, and tissue AR measurements based on this method are also invalid, and should be reassessed. AR exhibits broad specificity for both hydrophilic and hydrophobic aldehydes that suggests that the protein may be involved in detoxification. The last thing we would want to do is to inhibit it. ARIs (AR inhibitors) have a number of actions in the cell which are not specific, and which do not involve them binding to AR. These include peroxy-radical scavenging and effects of metal ion chelation. The AR/ARI story emphasizes the importance of correct experimental design in all biocatalytic experiments. Developing the use of Bayesian utility functions, we have used a systematic method to identify the optimum experimental designs for a number of kinetic model data sets. This has led to the identification of trends between kinetic model types, sets of design rules and the key conclusion that such designs should be based on some prior knowledge of K m and/or the kinetic model. We suggest an optimal and iterative method for selecting features of the design such as the substrate range, number of measurements and choice of intermediate points. The final design collects data suitable for accurate modelling and analysis and minimizes the error in the parameters estimated, and is suitable for simple or complex steady-state models.
peroxide is produced by the autoxidation of the ene-diols ascorbate and dihydroxyfumarate via superoxide, hydroxyl and free-radical intermediates. Monosaccharides undergo similar autoxidative processes to yield free radicals [6] . The formation of an ene-diol C(OH) C(OH) is a prerequisite to autoxidation [7, 8] . The ene-diol intermediate autoxidizes rapidly to form hydrogen peroxide and an α-ketoaldehyde via hydroxyl, superoxide and carbon-centred free radicals. Ferricytochrome c is reduced by a number of autoxidizing monosaccharides, while reduction was inhibited 38% by copper/zinc superoxide dismutase; methylglyoxal reduced ferricytochrome c at a rate 74% that of glyceraldehyde. Glyceraldehyde produced hydroxypyruvaldehyde in the presence of oxygen, and the rate of iodine uptake (a measure of enolization) increased as physiological temperatures were approached. Radical formation was detected by ESR spintrapping [6, 8] . The monosaccharide enolizes to form an enediol which subsequently autoxidizes to produce hydroxyl, peroxide and superoxide radicals. The ene-diol itself produces an α-dicarbonyl compound via an ene-diol oxyradical and a carbon-centred radical.
Monosaccharide autoxidation is important in a number of ways. All products are potentially toxic to the cell, and at high levels their formation may exceed the detoxification capacity of the cell, exemplified by superoxide dismutase, glutathione peroxidase and the glutathione/glyoxylase system. As mentioned in other papers in this colloquium, an autoxidative component is quantitatively important in protein-adduct formation.
AR (aldose reductase) and monosaccharide autoxidation: the reason that activity can be measured in many tissues
The accumulation of sorbitol and xylitol in diabetic lenses has been attributed to the activity of the protein known as AR. However, there are a number of serious criticisms of the proposal of a role for that protein both as an enzyme in the classical sense, and as an agent in the aetiology of diabetic complications in humans.
Since AR activity is normally assayed by the co-incubation of tissue homogenates, aldoses (usually D,L-glyceraldehyde, which autoxidizes rapidly) and NADPH, it was reasonable to speculate that NADPH consumption could result from freeradical-mediated oxidation. Peroxyl and other free radicals are known for their ability to oxidize reduced nucleotides, particularly in the presence of nucleotide-binding proteins.
It was observed using a specific HPLC technique [9, 10] that NADPH-oxidizing activity was not linked to polyol production using homogenates or purified enzymes. It was then shown that the steady-state properties of AR could be reproduced in vitro, owing to autoxidation-derived species causing oxidation of the NADPH [11] [12] [13] . NADPH oxidation was produced by glyceraldehyde and buffer incubations alone, and showed a concentration-dependence that mirrored that of an enzyme. NADPH oxidation was dependent upon phosphate concentration. Cytochrome c reduction and NADPH oxidation showed parallel temperature activation curves. The level of catalytic rate enhancementthe k cat /K m value -for glucose with AR was about 10 9 -fold lower than the diffusion-controlled encounter frequency (see [13] ). The level of enhancement was no greater for AR than for other NADPH-binding proteins (glutathione reductase, isocitrate dehydrogenase and glucose-6-phosphate dehydrogenase), and was very low compared with that of well characterized enzymes (about 10 6 -fold). The concentrationdependent behaviour with glutathione reductase was linear and identical to that of AR, as was pH-dependent behaviour. Further evidence that NADPH oxidation is peroxy-radicalmediated is that superoxide dismutase caused the almost total inhibition of NADPH oxidation with both homogeneous and crude preparations of bovine lens and human erythrocyte AR [13] .
Thus we can see that any assay for AR based on the oxidation of NADPH in the presence of autoxidizing monosaccharides is invalid, and that tissue AR measurements based on this method are also invalid, and should be reassessed.
It is clear that the protein isolated as AR from the lens is capable of binding NADPH, and that histidine and arginine residues located at or near nucleotide-binding sites may be important in the binding or orientation of the reduced nucleotide. While there is no doubt as to the function of AR as an NADPH-binding protein, there must be doubt about its catalytic role within the cell. The three major characteristics of an enzyme reaction are its rate enhancement, its stereospecificity and its susceptibility to control. AR is remarkably deficient in all these areas. The substrate specificity shows a lack of stereospecificity with regard to some monosaccharides. D-and L-forms of arabinose and glucose show almost identical relative velocities, judged by the oxidation of NADPH. AR also shows very poor rate enhancement, as mentioned above.
AR exhibits broad specificity for both hydrophilic and hydrophobic aldehydes, that suggested that the protein may be involved in detoxification. Aldehydes that contain an aromatic ring were found to produce high oxidation of NADPH, consistent with crystallographic data that suggest that AR possesses a large hydrophobic binding site. However, there was little discrimination among different aromatic aldehydes. In addition, small hydrophilic aldehydes exhibited low K m values if the α-carbon was oxidized. Analysis of the binding of NADPH by fluorescence quenching techniques indicated that AR exhibited a higher affinity for NADPH than NADP + . Thus AR may have evolved from a protein that catalysed the reduction of a very broad range of aldehydes. HNE (4-hydroxynonenal), a reactive α-β-unsaturated aldehyde produced during oxidative stress, was an excellent 'substrate' [14, 15] . The protein displayed a K m of approx. 9 µM for HNE and 34 µM for the glutathione adduct of HNE (HNE-GS), assigning HNE and HNE-GS to be among the best natural 'substrates' of AR known so far and potentially exposing a new efficient detoxification route of HNE. Methylglyoxal is another excellent substrate [16] .
In mammalian tissues, carbohydrate 2-oxoaldehydes, or 'osones', formed by cleavage of carbohydrate residues from glycated proteins, cause damage to cells and tissues by crosslinking of proteins. Several osones are relatively good 'substrates' for the reduced, inactivated form of AR from human and pig muscle, and for aldehyde reductase (EC 1.1.1.2) from pig kidney. Since these proteins are relatively ubiquitous, they may serve to protect a large number of tissues from damage. Acrolein, a highly cytotoxic aldehyde, is a metabolic byproduct of the anti-neoplastic agent cyclophosphamide and is responsible for the development of haemorrhagic cystitis, a serious side effect of cyclophosphamide therapy. AR catalyses the NADPH-dependent reduction of acrolein to allyl alcohol (K m 80 µM, k cat 87 min −1 ). In addition to being a substrate, acrolein also produces a time-dependent increase in the activity of AR towards a variety of substrates; this involved initial binding of acrolein to a second site (K s 58 µM). In liver cancer, AR can contribute to drug resistance [17] . The action and substrate specificity of AR with a number of toxic aldehyde substrates has been reviewed [12] .
Diabetic mice develop cataract despite low AR levels [18] . Transgenic mice have been developed that overexpress AR in their lens epithelial cells, and it was found that they became susceptible to the development of diabetic and galactose cataracts. When the sorbitol dehydrogenase-deficient mutation was also present in the transgenic mice, greater accumulation of sorbitol and further acceleration of the formation of diabetic cataract developed [19] . Thus when mouse lens is able to express far greater levels of AR than are normally associated with cataract in a rat, cataract results, suggesting that interfering with the NADPH binding and flux levels, and/or the detoxification of toxic aldehydes -possibly involving free radicals and metal ions -has a deleterious effect.
Thus we can see that there is mounting evidence for the binding of reactive aldehyde moieties to the enzyme, and the involvement of AR in detoxification. The last thing we would want to do is to inhibit it.
Inhibitors of the AR reaction
A wide variety of compounds have been shown to inhibit the AR reaction, as measured by the change in absorbance at 340 nm (oxidation of NADPH) when autoxidizing monosaccharides were used as substrates (see [12] for a review). While these compounds do not act as general antioxidants, or interfere in monosaccharide autoxidation per se, they may react with some metal oxidant complex involved in the oxidation of the NADPH [12] . There is much evidence that ARIs (AR inhibitors) have effects other than that of inhibiting AR. They inhibit naphthalene cataract in the rat, improve erythrocyte viscosity and deformability, and stimulate glycosylated Na + /K + -ATPase [12] . None of these effects can be ascribed to a lowering of the sorbitol concentration as the initial step, and in some cases there is no alteration in sorbitol levels. We therefore see that there is little evidence from the ARIs themselves for the involvement of AR in the pathogenesis of diabetic complications.
Recently, ARIs have been registered in several countries for the improvement of glycaemic control. However, their efficacy is still controversial. ARIs inhibit the enhanced production of sorbitol in experimental animals. As such, they can never be more effective than normoglycaemia, and so their potential benefits and limitations should be considered relative to the effects of prolonged euglycaemia. The clinical effects of ARIs can be put into perspective by assessing the effects of improved glycaemic control attained in randomized trials of intensive insulin treatment [such as the Diabetes Control and Complications Trial (DCCT)] and after pancreatic transplantation. Although direct comparison of these three interventions is hampered by differences in the patient populations, duration and methods of follow-up and in the potency of ARIs, the effects of these three metabolic interventions and their course in time appear to be similar. For neuropathy, all three interventions induced an increase in average motor nerve conduction velocity of approx. 1 m/s during the first months of treatment. At the same time, improvement of painful symptoms may occur. These changes probably largely represent a metabolic amelioration of the condition of the nerves. At around the second year of treatment with all three forms of metabolic improvement, an acceleration of nerve conduction of a similar magnitude occurs, with signs of structural nerve regeneration and some sensory recuperation. Experience with ARIs in nephropathy is still limited, but similar improvements in glomerular filtration rate and, less consistently, in urinary albumin excretion were found during short-term normoglycaemia produced by all three forms of treatment. Comparison of a small number of studies, however, shows differences between intensive insulin regimens, pancreatic transplantation and ARIs in effects on retinopathy. Retinopathy often deteriorates temporarily in the early phases of improved glycaemic control, but this is not noted with ARIs. New microaneurysm formation was slightly reduced in a single long-term study with the ARI sorbinil, but the preventative effects on the overall levels of retinopathy seemed less strong than in normoglycaemia trials of similar duration.
ARIs, which when first introduced were proclaimed to be major advances in treating diabetic complications, have never produced the expected results. Problems with efficacy and toxicity have relegated most of this class of agents to historical interest. It may be that some drugs in current use are effective against complications. Aspirin-like analgesics lower fasting blood glucose levels in diabetics and non-diabetics and improve glucose tolerance. These compounds also have a protective effect against retinopathy and cataract (see [12] ). Proper clinical trials of these or similar compounds in relation to diabetic complications may prove surprising.
Xylose and xylitol
Xylose-fed young rats accumulate polyols, including xylitol, and develop cataractous lesions. However, while xylose-fed adult rats accumulate similar polyol levels to young rats, they fail to develop cataract, suggesting that the relationship between polyol levels and cataract is complex and may involve disturbance of metabolism in rapidly growing younger lenses. In order to understand how this could occur it is necessary to elucidate the pathway by which the lens xylitol accumulates. This was originally thought to be the product of direct reduction of xylose by the lens AR, but we have shown that accumulation of xylitol in the mammalian lens is related to glucuronate metabolism [20] .
Efficient and accurate experimental design for enzyme kinetics: Bayesian studies reveal a systematic approach
One wonders if ARIs would ever have been developed if basic investigations into the biochemistry and stoichiometry of AR had been carried out when the activity was first reported. This emphasizes the importance of correct experimental design in all biocatalytic experiments.
In areas such as drug development, clinical diagnosis and biotechnology research, acquiring details about the kinetic parameters of enzymes is crucial. The correct design of an experiment is critical to collecting data suitable for analysis, modelling and deriving the correct information. As classical design methods are not targeted to the more complex kinetics being frequently studied, attention is needed to estimate parameters of such models with low variance. We have demonstrated that a Bayesian approach (the use of prior knowledge) can produce major gains quantifiable in terms of information, productivity and accuracy of each experiment. Developing the use of Bayesian utility functions, we have used a systematic method to identify the optimum experimental designs for a number of kinetic model data sets [21, 22] . This has enabled the identification of trends between kinetic model types, sets of design rules and the key conclusion that such designs should be based on some prior knowledge of K m and/or the kinetic model.
We have developed an optimal and iterative method for selecting features of the design such as the substrate range, number of measurements and choice of intermediate points.
The final design collects data suitable for accurate modelling and analysis and minimizes the error in the parameters estimated, for both simple and complex enzymes. Our final method of design needs only a very rough prior estimate of the K m (or the ratio of K m values in complex systems) and knowledge of the number of parameters in the kinetic model equation to which the data is to be fitted. Table 1 shows what happens when an experiment is designed on the basis of different K m prior estimates (in varying degrees of poorness). Each experiment was designed based on our rules and using each K m prior estimate. We then simulated data for the designed set of substrate concentrations, with the knowledge that the actual K m is 0.53 mM. Simulation was performed for both five concentrations measured in triplicate and five single concentrations. The fitting of these data gave us the new estimates of K m and their errors. The results show that although the fitted values of K m are not exact and the errors are high if the prior estimate is more than 20% out, they are much more refined than the initial guess/estimate. For example, when the K m is estimated initially to be 10 mM (20 times greater than the actual), and the experiment designed with respect to that value, then the new estimate is 0.76 mM, which is only 1.5 times out. The error does, however, remain very high. This suggests that the Bayesian design is good enough to refine even a very poor estimate. Observe also that measuring five single points is enough to refine the estimate closer to the true value. The use of triplicate measurements as predicted is useful in reducing the error, but does not actually affect the parameter estimate. Therefore we propose that a five-point experiment designed on the basis of the very rough prior estimate is enough to gain a better estimate of K m . Then a repeat five-point experiment is necessary to further refine or check the new estimate of K m . Once these two short initial experiments have been carried out, the new value of K m can be taken and the experiment redesigned, and the five points measured in triplicate to obtain final estimates and their errors. The final step is to present the parameter estimates with the minimum error. Similar rules can be applied to complex enzymes [22] .
We have also demonstrated that our method can be directly applied to the study of other important kinetic systems, including drug transport, receptor binding, microbial culture and cell transport kinetics (E.F. Murphy, S.G. Gilmour and M.J.C. Crabbe, unpublished work). Using our methods, it is possible to markedly reduce the errors in the estimated parameters and increase efficiency and cost-effectiveness by reducing the necessary amount of experiments and data points measured.
